Feiguo Zhou
- Molecular Biology
- Hepatology top 5%
- Cancer Research top 10%
- Epidemiology
- Oncology
- Co-authors
- Chunfang GaoPeng QiXing GuTonghai DouHao WangGeng LiYunpeng ZhaoJun Ji
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (6 papers)Hepatitis B Virus Studies (5 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers)
- Cited by
- HepatologyCancer ResearchImmunology
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Feiguo Zhou
18 papers receiving 567 citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Molecular Biology 266
- Hepatology 191
- Cancer Research 180
- Epidemiology 154
- Oncology 126
Countries citing papers authored by Feiguo Zhou
This map shows the geographic impact of Feiguo Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiguo Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiguo Zhou more than expected).
Fields of papers citing papers by Feiguo Zhou
This network shows the impact of papers produced by Feiguo Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiguo Zhou. The network helps show where Feiguo Zhou may publish in the future.
Co-authorship network of co-authors of Feiguo Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Feiguo Zhou. A scholar is included among the top collaborators of Feiguo Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feiguo Zhou. Feiguo Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trialbreakdown → | 64 |
| 2 | 78 | |
| 3 | 32 | |
| 4 | 78 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 2 | |
| 8 | 35 | |
| 9 | 109 | |
| 10 | 38 | |
| 11 | 35 | |
| 12 | 50 | |
| 13 | 14 | |
| 14 | [Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma]. | 2 |
| 15 | 25 | |
| 16 | 1 | |
| 17 | [Treatment strategy for synchronous liver metastasis from colorectal cancer]. | 5 |
| 18 | Prevention and management of pleural effusion following hepatectomy in primary liver cancer. | 4 |
About Feiguo Zhou
Feiguo Zhou is a scholar working on Hepatology, Biological Psychiatry and Behavioral Neuroscience, having authored 18 papers that have together received 575 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Hepatitis B Virus Studies (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers). The work is most often cited by research in Hepatology (191 citations), Cancer Research (180 citations) and Immunology (113 citations). Feiguo Zhou has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Chunfang Gao, Peng Qi, Xing Gu, Tonghai Dou, Hao Wang, Geng Li, Yunpeng Zhao, Jun Ji, Hao Wang and Yan Li. Their work appears in journals such as Nature Medicine, PLoS ONE and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.